Full text
| |
| Author(s): |
Rodrigo Atique Ferraz de Toledo
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Biociências (IBIOC/SB) |
| Defense date: | 2012-02-15 |
| Examining board members: |
Maria Rita dos Santos e Passos Bueno;
Andrea Laurato Sertie Santos
|
| Advisor: | Maria Rita dos Santos e Passos Bueno |
| Abstract | |
Apert Syndrome is cause by gain of Function mutations in FGFR2, a rare condition characterized by craniosynostosis and bone limb defects due to abnormalities in osteogenic differentiation and cone remodeling. Even though the periosteum acts as an important cell source during bone remodeling, its role in craniosynostosis is yet unknown. Apert syndrome is caused by one of two mutations (p.S252W or p.P253R) leading to loss of specificity of FGFR2 by its ligands leading to increased activation of the receptor. It is known that FGFR2 activates the MEK/ERK, PI3-K and PLC signaling pathways. Our hypothesis is that Apert syndrome patients\'\' Mesenchimal Stem Cells (MSCs) and fibroblasts have altered cellular phenotye and signaling pathways which may contribute to the premature closure of the coronal sutures. MSCs and fibroblasts were obtained from the periosteum of Apert syndrome patients bearing the p.S252W mutation and from wild-type (WT) individuals. The p.S252W mutation had opposite effects on different cell types: MSCs p.S252W proliferated less than WT, while p.S252W fibroblasts showed increased proliferation and migration when compared to WT fibroblasts. The presence of the p.S252W mutation increased the osteogenical differentiation in vitro and in vivo in both cell types. We also demonstrated that p.S252W fibroblasts can increase the osteogenic differentiation of MSCs from the periosteum, but not from other sources. is negatively controlling the phosphorylation of JNK. We propose that cells from the periosteum have a more significant role in the premature closure of the cranial sutures than previously thought and that molecules of the JNK pathway are strong candidates for the treatment of Apert syndrome. Previous works have shown that the DUSP2 gene had increased expression in periosteum derived fibroblasts of Apert syndrome patients then in WT. DUSP2 is a phosphatase capable of dephosphorylate members of the MAPK family, including p-JNK. In this work we have shown that FGFR2 activation regulates the proteic levels of DUSP2 in both patients and control derived fibroblasts, however this control is exercised by different pathways in each case. We also demonstrated that DUSP2 (AU) | |
| FAPESP's process: | 09/03599-5 - Influence of Serotonin on the osteogenic capacity of mesenquimal stem-cells harboring mutations in the FGFR2 gene. |
| Grantee: | Rodrigo Atique Ferraz de Toledo |
| Support Opportunities: | Scholarships in Brazil - Master |